Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients in the ICU are already predisposed to nosocomial infections, which are both costly and potentially life threatening, and it appears that the immune paralysis of sepsis may put these patients at greater risk for secondary infections, though this has not been proven conclusively. One measure of this sepsis-induced immune suppression is monocyte deactivation. The investigators hypothesize that, as a cornerstone of the monocytic innate immune response to infection, the inflammasome is critical to monocyte function during sepsis.
Sepsis is a systemic inflammatory response to a severe infection. Despite the high incidence and societal costs of sepsis, the mechanism by which it kills remains unclear. The pathophysiology of sepsis is not completely understood, but many investigators now believe that sepsis induces a prolonged state of immune suppression. This study will attempt to quantify the degree of immune suppression during the first 5 days of sepsis by measuring the immune function of peripheral blood monocytes and the inflammasome constituent proteins in peripheral blood monocytes and alveolar macrophages.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sepsis | Patients who have been diagnosed with Sepsis within 24 hours of admission | ||
| Non-Septic | Patients who have not been diagnosed with sepsis within 24 hours of admission |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Immune suppression during the recovery from critical illness is greater in severe sepsis patients compared to non-septic patients. | Blood and BAL fluid will be collected at Day 1 | Day 1 |
| Immune suppression during the recovery from critical illness is greater in severe sepsis patients compared to non-septic patients. | Blood and BAL fluid will be collected at Day 3 | Day 3 |
| Immune suppression during the recovery from critical illness is greater in severe sepsis patients compared to non-septic patients. | Blood and BAL fluid will be collected at Day 5 | Day 5 |
Not provided
Not provided
Inclusion Criteria:
≥ 18 years.
Have consensus criteria for sepsis (infection plus two of four systemic inflammatory response syndrome [SIRS] signs [tachycardia, tachypnea, fever or hypothermia, leukocytosis or leukopenia]) and a known or suspected infection for SEPTIC arm.
Exclusion Criteria:
Not provided
Not provided
Not provided
This study will be open to males and females, 18 years or older, who spend at least one day on mechanic ventilation in the Ohio State University Medical Intensive Care Unit
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Matthew Exline, M.D. | Ohio State University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| The Ohio State University | Columbus | Ohio | 43221 | United States |
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Peripheral blood Bronchoalveolar lavage fluid
| D013568 |
| Pathological Conditions, Signs and Symptoms |